Cardiovascular revascularization medicine : including molecular interventions
-
Cardiovasc Revasc Med · May 2011
Multicenter StudyPercutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred management strategy for the prevention of recurrent cerebrovascular events in patients with cryptogenic stroke and presumed paradoxical embolus. There is limited outcome data in patients treated with this therapy particularly for the newer devices. ⋯ PFO causing presumed paradoxical embolism can be closed percutaneously with a low rate of significant residual shunting and very few complications. Recurrent index events are uncommon at medium-term (up to 4 years) follow-up.